Literature DB >> 18334919

High arsenic metabolic efficiency in AS3MT287Thr allele carriers.

Alba Hernández1, Noel Xamena, Chandra Sekaran, Hiroshi Tokunaga, Adriana Sampayo-Reyes, Domingo Quinteros, Amadeu Creus, Ricardo Marcos.   

Abstract

OBJECTIVES: Epidemiological data indicate the existence of wide interindividual differences in arsenic metabolism. It has recently been shown that arsenic(III)methyltransferase (AS3MT) enzyme catalyses the methylation of arsenite and monomethylarsonous acid (MMA). Thus, genetic variations in the AS3MT gene could explain, at least partly, the interindividual variation in the response to arsenic exposure. In an earlier study, we have demonstrated that the AS3MT Met(287)Thr (C/T) polymorphism affected the urinary arsenic profile in a Chilean group of men (n=50) occupationally exposed to arsenic.
METHODS: To confirm, the influence of the Met(287)Thr polymorphism in the metabolism of arsenic, a total of 207 Chilean men working at the copper industry were genotyped and their urinary profiles determined.
RESULTS: The results confirm that Met(287)Thr polymorphism does influence arsenic metabolism in this population. Those carriers of the variant ((287)Thr) had a higher methylation efficiency, excreting 4.63% more MMA in urine (P=0.0007) and presenting a 2.98 times higher odd of excreting levels of MMA over the standard (P=0.011) than the participants homozygous for the normal allele.
CONCLUSION: We can conclude that individuals with the (287)Thr variant display increased arsenic methylation; thus, those participants might be at increased risk for the toxic and genotoxic effects of arsenic exposure.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18334919     DOI: 10.1097/FPC.0b013e3282f7f46b

Source DB:  PubMed          Journal:  Pharmacogenet Genomics        ISSN: 1744-6872            Impact factor:   2.089


  28 in total

1.  Indigenous American ancestry is associated with arsenic methylation efficiency in an admixed population of northwest Mexico.

Authors:  Paulina Gomez-Rubio; Yann C Klimentidis; Ernesto Cantu-Soto; Maria M Meza-Montenegro; Dean Billheimer; Zhenqiang Lu; Zhao Chen; Walter T Klimecki
Journal:  J Toxicol Environ Health A       Date:  2012

2.  Arsenic exposure and toxicology: a historical perspective.

Authors:  Michael F Hughes; Barbara D Beck; Yu Chen; Ari S Lewis; David J Thomas
Journal:  Toxicol Sci       Date:  2011-07-12       Impact factor: 4.849

3.  Analysis of maternal polymorphisms in arsenic (+3 oxidation state)-methyltransferase AS3MT and fetal sex in relation to arsenic metabolism and infant birth outcomes: Implications for risk analysis.

Authors:  Zuzana Drobná; Elizabeth Martin; Kyung Su Kim; Lisa Smeester; Paige Bommarito; Marisela Rubio-Andrade; Gonzalo G García-Vargas; Miroslav Stýblo; Fei Zou; Rebecca C Fry
Journal:  Reprod Toxicol       Date:  2016-02-27       Impact factor: 3.143

4.  A transgenic Drosophila model for arsenic methylation suggests a metabolic rationale for differential dose-dependent toxicity endpoints.

Authors:  Jorge G Muñiz Ortiz; Junjun Shang; Brittany Catron; Julio Landero; Joseph A Caruso; Iain L Cartwright
Journal:  Toxicol Sci       Date:  2011-03-29       Impact factor: 4.849

5.  Structure of an As(III) S-adenosylmethionine methyltransferase: insights into the mechanism of arsenic biotransformation.

Authors:  A Abdul Ajees; Kavitha Marapakala; Charles Packianathan; Banumathi Sankaran; Barry P Rosen
Journal:  Biochemistry       Date:  2012-06-29       Impact factor: 3.162

6.  GSTO and AS3MT genetic polymorphisms and differences in urinary arsenic concentrations among residents in Bangladesh.

Authors:  Ema G Rodrigues; Molly Kile; Elaine Hoffman; Quazi Quamruzzaman; Mahmuder Rahman; Golam Mahiuddin; Yumei Hsueh; David C Christiani
Journal:  Biomarkers       Date:  2012-02-18       Impact factor: 2.658

7.  Environmental exposure to arsenic, AS3MT polymorphism and prevalence of diabetes in Mexico.

Authors:  Zuzana Drobná; Luz M Del Razo; Gonzalo G García-Vargas; Luz C Sánchez-Peña; Angel Barrera-Hernández; Miroslav Stýblo; Dana Loomis
Journal:  J Expo Sci Environ Epidemiol       Date:  2012-10-24       Impact factor: 5.563

8.  Polymorphisms in maternal folate pathway genes interact with arsenic in drinking water to influence risk of myelomeningocele.

Authors:  Maitreyi Mazumdar; Linda Valeri; Ema G Rodrigues; Md Omar Sharif Ibne Hasan; Rezina Hamid; Ligi Paul; Jacob Selhub; Fareesa Silva; Md Golam Mostofa; Quazi Quamruzzaman; Mahmuder Rahman; David C Christiani
Journal:  Birth Defects Res A Clin Mol Teratol       Date:  2015-08-06

9.  Association of AS3MT polymorphisms and the risk of premalignant arsenic skin lesions.

Authors:  Olga L Valenzuela; Zuzana Drobná; Erika Hernández-Castellanos; Luz C Sánchez-Peña; Gonzalo G García-Vargas; Víctor H Borja-Aburto; Miroslav Stýblo; Luz M Del Razo
Journal:  Toxicol Appl Pharmacol       Date:  2009-06-16       Impact factor: 4.219

10.  Methylation of arsenic by recombinant human wild-type arsenic (+3 oxidation state) methyltransferase and its methionine 287 threonine (M287T) polymorph: Role of glutathione.

Authors:  Lan Ding; R Jesse Saunders; Zuzana Drobná; Felecia S Walton; Pencheng Xun; David J Thomas; Miroslav Stýblo
Journal:  Toxicol Appl Pharmacol       Date:  2012-07-31       Impact factor: 4.219

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.